Monitor Q2 2026 for impairment charges related to the eyewear transfer and any impact on guidance. The Medical segment's continued growth and margin expansion are positive, but Manufacturing weakness and flat total revenue warrant caution. Watch for management's commentary on the conference call for segment trends.
Price Chart
Executive Summary
Materialise reported stable Q1 2026 revenue of €66.3M (flat YoY) but swung to a net profit of €1.8M from a loss of €0.5M, driven by margin expansion and cost control. The company also announced the transfer of its eyewear business to management (with expected Q2 impairment charges) and reaffirmed full-year guidance. The Medical segment grew 6.7%, offset by declines in Software (-1.4%) and Manufacturing (-8.1%).
Key Facts
- Q1 2026 total revenue flat at €66,276k vs €66,379k YoY
- Net profit of €1,820k vs net loss of €535k YoY
- Adjusted EBIT rose to €2,470k from €646k YoY
- Medical segment revenue +6.7%, Software -1.4%, Manufacturing -8.1%
- Gross margin improved to 57.2% from 55.3% YoY
- Net cash position increased €2,021k to €72,826k
- Transferred eyewear business to management; expects Q2 2026 impairment charges
- Reaffirmed FY2026 guidance: revenue €273M-€283M, Adjusted EBIT €10M-€12M
Financial Impact
Net profit improved by ~€2.4M YoY; impairment charges expected in Q2 2026 (undisclosed amount)
Risk Factors
- Impairment charges in Q2 2026 from eyewear transfer could weigh on earnings
- Manufacturing segment revenue declining 8.1% may signal further weakness
- Macroeconomic and geopolitical uncertainty may persist, impacting growth
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-057219 |
| Document: tm2613875d1_6k.htm | 0001104659-26-057219 |
| Document: 0001104659-26-057219-index-headers.html | 0001104659-26-057219 |
| Document: 0001104659-26-057219-index.html | 0001104659-26-057219 |
| Document: 0001104659-26-057219.txt | 0001104659-26-057219 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $8.65 | awaiting T+20 | — | $8.65 (−0.00%) |
Oct 19, 2026 7d ago | 6-K | $8.21 | awaiting T+20 | — | $8.65 (+5.36%) |
Oct 13, 2026 13d ago | 6-K | $8.13 | awaiting T+20 | — | $8.65 (+6.40%) |
Oct 5, 2026 21d ago | 6-K | $8.56 | awaiting T+20 | — | $8.65 (+1.05%) |
Sep 8, 2026 6w ago | 6-K | $7.46 $8.50 | ▲ +13.94% | ▲ +11.74% | $8.65 (+15.95%) |
Aug 28, 2026 8w ago | 6-K | $7.21 $8.75 | ▲ +21.36% | ▲ +21.73% | $8.65 (+19.97%) |
Jul 20, 2026 14w ago | 6-K | $6.60 $6.69 | ▲ +1.36% | ▼ −1.20% | $8.65 (+31.06%) |
Jul 13, 2026 15w ago | 6-K | $6.77 $6.87 | ▲ +1.48% | ▼ −1.01% | $8.65 (+27.77%) |
Jul 6, 2026 16w ago | 6-K | $7.04 $6.51 | ▼ −7.53% | ▼ −8.86% | $8.65 (+22.87%) |
Jun 29, 2026 17w ago | 6-K | $7.43 $6.44 | ▼ −13.32% | ▼ −12.30% | $8.65 (+16.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers